Liver adenomatosis: Re-evaluation of aetiology and management

Liver International

Volumn 28, Issue 4, 2008, Pages 499-508

  Veteläinen, Reeta ^a   Erdogan, Deha ^a   De Graaf, Wilmar ^a   Ten Kate, Fiebo ^a   Jansen, Peter L M ^a   Gouma, Dirk J ^a   van Gulik, Thomas M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adenomatosis; Diagnosis; Treatment

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG USE; FATTY LIVER; FEMALE; FOLLOW UP; HEMIHEPATECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER ADENOMATOSIS; LIVER HEMORRHAGE; LIVER TUMOR; MEDLINE; NON INVASIVE MEASUREMENT; PAIN; PATHOGENESIS; PROGNOSIS; TUMOR REGRESSION;

ADENOMA, LIVER CELL; ADULT; BIOPSY, NEEDLE; COHORT STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 40949125300     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01669.x     Document Type: Article

References (57)

1. Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976; 294: 470-2.
2. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988; 208: 558-64.
3. Buhler H, Pirovino M, Akobiantz A, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982; 82: 775-82.
4. Flejou JF, Barge J, Menu Y, et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985; 89: 1132-8.
5. Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: Results with a conservative surgical approach. Liver Transpl Surg 1998; 4: 388-98.
6. Chiche L, Dao T, Salame E, et al. Liver adenomatosis: Reappraisal, diagnosis, and surgical management: Eight new cases and review of the literature. Ann Surg 2000; 231: 74-81.
7. Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: Clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000; 216: 395-402.
8. Brander WL, Vosnides G, Ogg CS, West IE. Multiple hepatocellular tumours in a patient treated with oral contraceptives. Virchows Arch A Pathol Anat Histol 1976; 370: 69-76.
9. Brophy CM, Bock JF, West AB, McKhann CF. Liver cell adenoma: Diagnosis and treatment of a rare hepatic neoplastic process. Am J Gastroenterol 1989; 84: 429-32.
10. Erdogan D, van Delden OM, Busch OR, Gouma DJ, van Gulik TM. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas. Cardiovasc Intervent Radiol 2007; 30: 1252-8.
11. Brunt EM, Wolverson MK, Di Bisceglie AM. Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: A case report. Semin Liver Dis 2005; 25: 230-6.
12. Bluteau O, Jeannot E, Bioulac-Sage P, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32: 312-5.
13. Bacq Y, Jacquemin E, Balabaud C, et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 2003; 125: 1470-5.
14. Monges H, Payan H, Legre M, Vignoli R. Considerations on a case of benign multinodular adenoma of the liver. Arch Mal Appar Dig Mal Nutr 1963; 52: 725-37.
15. Monaco AP, Hallgrimsson J, McDermott WV Jr. Multiple adenoma (hamartoma) of the liver treated by subtotal (90 percent) resection: Morphological and functional studies of regeneration. Ann Surg 1964; 159: 513-9.
16. Bertrand G, Saint-Andre JP, Simard C, Pillet J, Sulzer J. Letter: nodular liver hyperplasia after oral contraception. 2 new cases. Nouv Presse Med 1975; 4: 2276.
17. Bisson A, Duron JJ, Fagniez PL, Pinaudau Y, Germain A. Hepatic adenomatosis and oral contraceptives. Surgical aspects. Nouv Presse Med 1974; 3: 2079-82.
18. Caquet R, Guillausseau PJ, Louvel A, d'Izarn JJ, Laroche C, Leger L. Hepatic polyadenomatosis. A further case. Nouv Presse Med 1976; 5: 1474-6.
19. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994; 129: 712-7.
20. Mariani AF, Livingstone AS, Pereiras RV Jr, van Zuiden PE, Schiff ER. Progressive enlargement of a hepatic cell adenoma. Gastroenterology 1979; 77: 1319-25.
21. Lui AF, Hiratzka LF, Hirose FM. Multiple adenomas of the liver. Cancer 1980; 45: 1001-4.
22. Sinha MR, Prasad SB. Multiple adenomas of the liver. J Indian Med Assoc 1982; 79: 16-8.
23. Chen KT, Bocian JJ. Multiple hepatic adenomas. Arch Pathol Lab Med 1983; 107: 274-5.
24. Kalra PA, Guthrie JA, Dibble JB, Turney JH, Brownjohn AM. Hepatic adenomas induced by norethisterone in patients receiving renal dialysis. Br Med J (Clin Res Ed) 1987; 294: 808.
25. Leborgne J, Lehur PA, Horeau JM, et al. Therapeutic problems caused by rupture of large hepatic adenoma with central location. Apropos of 3 cases. Chirurgie 1990; 116: 454-60.
26. Choi BI, Han JK, Kim SH, Han MC. MR findings in liver adenomatosis. Gastrointest Radiol 1991; 16: 234-6.
27. Khan SS, Fink M, King S. Case report: Liver adenomatosis presenting as multiple calcified masses. Clin Radiol 1992; 45: 206-7.
28. Le BB, Jouhanole H, Deugnier Y, et al. Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. Am J Surg Pathol 1992; 16: 982-7.
29. Propst A, Propst T, Waldenberger P, Vogel W, Judmaier G. A case of hepatocellular adenomatosis with a follow-up of 11 years. Am J Gastroenterol 1995; 90: 1345-6.
30. Arsenault TM, Johnson CD, Gorman B, Burgart LJ. Hepatic adenomatosis. Mayo Clin Proc 1996; 71: 478-80.
31. Barcet S, Frering V, Partensky C. Resection hépatique pour adenoma et adénomatose hépatique. Lyon Chir 1996; 92: 6-12.
32. Gokhale R, Whitington PF. Hepatic adenomatosis in an adolescent. J Pediatr Gastroenterol Nutr 1996; 23: 482-6.
33. Cristaldi M, Rovati M, Conte D, et al. Primary liver adenomatosis: report of two cases and literature review. Dig Surg 1998; 15: 75-8.
34. Oberti F, Rifflet H, Flejou JF, et al. Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti. Gastroenterol Clin Biol 1997; 21: 147-51.
35. Ye MQ, Suriawinata A, Ben HM, Parsons R, Schwartz ME. A 42-year-old woman with liver masses and long-term use of oral contraceptives. Semin Liver Dis 1999; 19: 339-44.
36. Caballes RL, Caballes RA. Multiple hepatocellular adenomas in a patient with a history of oral contraception. Int J Gynaecol Obstet 1999; 64: 177-80.
37. Yoshidome H, McMasters KM, Edwards MJ. Management issues regarding hepatic adenomatosis. Am Surg 1999; 65: 1070-6.
38. Suarez AA, Brunt EM, Di Bisceglie AM. A 35-year-old woman with progesterone implant contraception and multiple liver masses. Semin Liver Dis 2001; 21: 453-9.
39. Jovine E, Biolchini F, Talarico F, et al. Intrahepatic rupture of a caudate lobe adenoma in liver adenomatosis. J Hepatobiliary Pancreat Surg 2004; 11: 324-9.
40. Lee SH, Hahn ST. Treatment of multiple hepatic adenomatosis using transarterial chemoembolization: A case report. Cardiovasc Intervent Radiol 2004; 27: 563-5.
41. Lepreux S, Laurent C, Blanc JF, et al. The identification of small nodules in liver adenomatosis. J Hepatol 2003; 39: 77-85.
42. Skarupa DJ, Ellison EC, Vitellas KM, Frankel WL. Hepatocellular adenomatosis is a rare entity that may mimic other hepatocellular lesions. Ann Diagn Pathol 2004; 8: 43-9.
43. Jenkins RL, Johnson LB, Lewis WD. Surgical approach to benign liver tumors. Semin Liver Dis 1994; 14: 178-89.
44. Svrcek M, Jeannot E, Arrive L, et al. Regressive liver adenomatosis following androgenic progestin therapy withdrawal: A case report with a 10-year follow-up and a molecular analysis. Eur J Endocrinol 2007; 156: 617-21.
45. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
46. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol 2006; 58: 236-45.
47. Welch TJ, Sheedy PF, Johnson CM, et al. Focal nodular hyperplasia and hepatic adenoma: Comparison of angiography, CT, US, and scintigraphy. Radiology 1985; 156: 593-5.
48. Brancatelli G, Federle MP, Grazioli L, Blachar A, Peterson MS, Thaete L. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001; 219: 61-8.
49. Pastor CM, Planchamp C, Pochon S, et al. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology 2003; 229: 119-25.
50. Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: A magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54: 122-7.
51. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387-95.
52. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396-400.
53. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991; 173: 426-31.
54. Tanaka K, Nakamura S, Numata K, et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82: 78-85.
55. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46.
56. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-44.
57. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002; 6: 88-94.